In this recording from the 2022 HealthPlus Fertility Middle East Conference, our Co-Founder and Chief Medical Officer, Dr. Dan Nayot, discusses the clinical application of artificial intelligence (AI) in assessing oocyte quality. This video provides a high-level overview for embryologists and REIs on the following topics:
• The importance of evaluating oocyte quality as part of cryopreservation and IVF
• The fundamentals of AI-based image analysis in the case of oocytes
• Comparison of manual oocyte evaluation methods vs. AI
• The benefits of AI oocyte assessment for the patient experience:
• Managing expectations for success, failed cycle counselling and future IVF cycle planning
• Delivering personalized live birth predictions for egg freezers beyond general age-based predictions
• Questions to consider when critically evaluating papers regarding AI in medicine